Xenon Pharmaceuticals, Inc. (XENE)
60.54
-0.23
(-0.38%)
USD |
NASDAQ |
Aug 24, 16:00
60.54
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Total Liabilities (Quarterly) : 53.38M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.38M |
| March 31, 2026 | 48.99M |
| December 31, 2025 | 399.91M |
| September 30, 2025 | 48.32M |
| June 30, 2025 | 40.30M |
| March 31, 2025 | 39.32M |
| December 31, 2024 | 312.19M |
| September 30, 2024 | 38.09M |
| June 30, 2024 | 39.96M |
| March 31, 2024 | 31.32M |
| December 31, 2023 | 36.88M |
| September 30, 2023 | 34.50M |
| June 30, 2023 | 38.44M |
| March 31, 2023 | 32.92M |
| December 31, 2022 | 32.65M |
| September 30, 2022 | 22.69M |
| June 30, 2022 | 21.59M |
| March 31, 2022 | 16.21M |
| December 31, 2021 | 21.97M |
| September 30, 2021 | 15.41M |
| June 30, 2021 | 17.73M |
| March 31, 2021 | 14.39M |
| December 31, 2020 | 17.83M |
| September 30, 2020 | 17.10M |
| June 30, 2020 | 21.38M |
| Date | Value |
|---|---|
| March 31, 2020 | 49.06M |
| December 31, 2019 | 55.72M |
| September 30, 2019 | 24.34M |
| June 30, 2019 | 23.10M |
| March 31, 2019 | 22.24M |
| December 31, 2018 | 19.13M |
| September 30, 2018 | 19.30M |
| June 30, 2018 | 14.82M |
| March 31, 2018 | 9.264M |
| December 31, 2017 | 10.19M |
| September 30, 2017 | 3.058M |
| June 30, 2017 | 3.774M |
| March 31, 2017 | 3.591M |
| December 31, 2016 | 3.586M |
| September 30, 2016 | 4.062M |
| June 30, 2016 | 3.03M |
| March 31, 2016 | 2.989M |
| December 31, 2015 | 2.915M |
| September 30, 2015 | 5.485M |
| June 30, 2015 | 12.18M |
| March 31, 2015 | 10.43M |
| December 31, 2014 | 14.64M |
| September 30, 2014 | 19.16M |
| June 30, 2014 | 23.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Psyence Biomedical Ltd. | 0.9431M |
| Aurinia Pharmaceuticals, Inc. | 177.40M |
| enGene Therapeutics, Inc. | 52.36M |
| Medicus Pharma Ltd. | 20.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.296B |
| Shareholders Equity (Quarterly) | 1.242B |
| Debt to Equity Ratio | 0.0052 |
| Current Ratio | 21.02 |
| Net Debt Paydown Yield | 0.01% |